A study of regulations combating counterfeit medicines across India, USA, and Europe

被引:0
|
作者
Nori, Lakshmi Prasanthi [1 ]
Varma, T. Srinivas [1 ]
Nulu, Lakshmi Sri Naga Valli [1 ]
Raju, K. Venkateswara [1 ]
机构
[1] Shri Vishnu Coll Pharm, Dept Regulatory Affairs, Bhimavaram, Andhra Pradesh, India
关键词
Blockchain; counterfeit; customs and board protection; falsified; pharmaceutical; serialization; spurious/falsely labeled/falsified/counterfeit;
D O I
10.4103/ajprhc.ajprhc_39_23
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Counterfeiting is the deliberate and fraudulent production of products including mislabeling in attempts to deliberately morph its identity and source for making its appearance as genuine and as it is concerning the original product. Counterfeit medicines are pharmaceutical medicinal products without anyActive pharmaceutical ingredient (API), substandard quality API, or a fraction of the original amount of API stated as a different API, cross-contaminated API, and expiry products that are repacked including formulations done incorrectly and produced in substandard conditions. Expensive drug's extensive demand like steroids, antibiotics, cancer-treating drugs, vaccines, antivirals, and antihistamines are targets for counterfeiting. Patients deceived into buying counterfeit drugs are people seeking to buy discounted medications and involved in inappropriate usage. With identical labels as well as nearly resemblance to originals, these counterfeits are cheaper to make. Counterfeit medicines kill and threaten the lives of abused patients, fooled by false appearances. Medicines and health-care items are different from other commodities, and their fakes are different from other fakes. They are deceived by misleading characteristics and harm and risk the lives of several mistreated victims daily. This variety of terms and definitions, which might differ from one nation to the next, leads to a lack of awareness of the issue on a worldwide scale. The European Union's mainly prefers the term "counterfeiting," lately the phrase "falsification" even if the US uses the phrase "false" or "fake" more. We must comprehend the phrase "medicine" and its meanings to define the many terminologies used to describe counterfeiting.
引用
收藏
页码:115 / 123
页数:9
相关论文
共 50 条
  • [1] The role of German official medicines control laboratories in combating counterfeit medicines
    Wiegard, Andrea
    Heuermann, Matthias
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2017, 60 (11) : 1214 - 1220
  • [2] Combating Sale of Counterfeit and Falsified Medicines Online: A Losing Battle
    Lee, Kah Seng
    Yee, Siew Mei
    Zaidi, Syed Tabish Razi
    Patel, Rahul P.
    Yang, Quan
    Al-Worafi, Yaser Mohammad
    Ming, Long Chiau
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [3] Front Line of Combating Counterfeit Medicines, Globally and Locally Foreword
    Kimura, Kazuko
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2014, 134 (02): : 195 - 196
  • [4] Counterfeit medicines sale on online pharmacies in India
    Nagaraj, Anup
    Tambi, Swasti
    Shravani, G.
    Biswas, Gautam
    Kumawat, Himanshu
    Mathur, Gaurav
    JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2014, 3 (04) : 145 - 146
  • [5] An exploratory assessment of the legislative framework for combating counterfeit medicines in South Africa
    Moshoeshoe, R. J.
    Enslin, G. M.
    Katerere, D. R.
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2022, 15 (01)
  • [6] Commentary: Combating Sale of Counterfeit and Falsified Medicines Online: A Losing Battle
    Huang, Baobin
    Xu, Mingzhe
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [7] An exploratory assessment of the legislative framework for combating counterfeit medicines in South Africa
    R. J. Moshoeshoe
    G. M. Enslin
    D. R. Katerere
    Journal of Pharmaceutical Policy and Practice, 15
  • [8] Combating Counterfeit Medicines and Illicit Trade in Tobacco Products: Minefields in Global Health Governance
    Liberman, Jonathan
    JOURNAL OF LAW MEDICINE & ETHICS, 2012, 40 (02): : 326 - 347
  • [9] Review of the Regulations for Clinical Research in Herbal Medicines in USA
    Tony Yuqi Tang
    李方舟
    Janyne Afseth
    Chinese Journal of Integrative Medicine, 2014, 20 (12) : 883 - 893
  • [10] Review of the regulations for clinical research in herbal medicines in USA
    Tony Yuqi Tang
    Fang-zhou Li
    Janyne Afseth
    Chinese Journal of Integrative Medicine, 2014, 20 : 883 - 893